Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Risk of bias in randomized controlled trials of psychological treatments for bulimia nervosa and binge eating

Texto completo
Autor(es):
Trevizo, Juliana Pagotto [1] ; Hay, Phillipa [2, 3] ; Swardfager, Walter [4, 5] ; Cogo-Moreira, Hugo [1]
Número total de Autores: 4
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo, Dept Psychiat, BR-04039032 Sao Paulo - Brazil
[2] Western Sydney Univ, Sch Med, Sydney, NSW - Australia
[3] Western Sydney Univ, Translatinal Inst Hlth Res, Sydney, NSW - Australia
[4] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON - Canada
[5] Sunnybrook Res Inst, Hurvitz Brain Sci Program, Toronto, ON - Canada
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: ANNALS OF EPIDEMIOLOGY; v. 28, n. 9, p. 625-628, SEP 2018.
Citações Web of Science: 0
Resumo

Purpose: In the context of Cochrane systematic reviews/meta-analyses of randomized clinical trials, risk of bias (RoB) is assessed using categorical indicators (low, unclear, or high RoB). This study sought to evaluate the indicators of the Cochrane RoB tool available for construct validity as applied to randomized clinical trials of psychological treatments for bulimia nervosa and binge eating. Methods: Bayesian confirmatory factor analysis was used to test the construct validity of the measurement model underlying the set of five categorical items, and the reliability of these indicators to measure RoB. Results: In 48 primary randomized clinical trials, the model showed good fit indices and factor loadings higher than 0.4. Conclusions: The results support the construct validity of the Cochrane RoB tool and the reliability of three of five items in this health intervention context. (C) 2018 Elsevier Inc. All rights reserved. (AU)

Processo FAPESP: 16/12703-4 - O modelo de avaliação de risco de vieses proposto pela Cochrane se mostra bem ajustado quando aplicado a ensaios clínicos sobre tratamentos psicológicos para bulimia nervosa e "binge"?
Beneficiário:Juliana Pagotto Trevizo
Linha de fomento: Bolsas no Brasil - Iniciação Científica